Background The majority of those infected by ancestral Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) during the UK first wave (starting March 2020) did not require …

Aims Long-COVID occurs after SARS-CoV-2 infection and results in diverse, prolonged
symptoms. The present study aimed to unveil potential mechanisms, and to inform prognosis …

Development of effective therapies against SARS-CoV-2 infections relies on mechanistic
knowledge of virus-host interface. Abundant physical interactions between viral and host …

Despite significant progress in understanding SARS-CoV-2 and its impact, a deeper
comprehension of the molecular changes in the host following infection is still lacking …

Abstract Coronavirus disease 2019 (COVID‐19) is a systemic inflammatory condition with
high mortality that may benefit from personalized medicine and high‐precision approaches …

Background SARS-CoV-2 infected patients show heterogeneous clinical presentations
ranging from mild symptoms to severe respiratory failure and death. Consequently, various …

Although the COVID-19 pandemic has ended, it is important to understand the pathology of
severe SARS-CoV-2 infection associated with respiratory failure and high mortality. The …

In recent years, we have seen the widespread devastations and serious health
complications manifested by COVID-19 globally. Although we have effectively controlled the …

Eukaryotic post-translational arginylation, mediated by the family of enzymes known as the
arginyltransferases (ATE1s), is an important post-translational modification that can alter …

The COVID-19 pandemic, triggered by severe acute respiratory syndrome coronavirus 2,
has affected millions of people worldwide. Much research has been dedicated to our …